GENE ONLINE|News &
Opinion
Blog

BioJapan
Japan’s Red Biotechnology and International Business Partnering Take Spotlight on BioJapan 2023
2023-11-03
Bio Japan 2021 Highlights: The Commercialization of iPS Cells and the Key to Improving Clinical Trials
2022-02-14
Spotlight on Bio Japan 2021: How Data Governance Can Prepare Us for The Future in Global Healthcare
2021-12-09
2021 BioJapan Highlights: How Can Metabolomics and Lipidomics Deepen Microbiome Research?
2021-10-14
Weekly in Asia|Oct-1
2019-10-14
BioJapan 2019 Kicks Off with Importances on New Bioeconomy Strategy
2019-10-10
Highlights on BioJapan 2018 – Updates on the Development of Cell Therapy and the Regenerative Medicine Ecosystem in Japan
2018-10-22
Live Report – 2018 BioJapan: Witness Japan’s biotechnology industry development policy and the innovation of pharmaceutical industry
2018-10-11
LATEST
The Golden Age of Medicine: Advancements in Novel Modalities and Therapeutic Areas
2024-11-01
Strengthening Biotech Ties: Highlights from the BioConnect Forum and Future Collaboration between Taiwan and Australia
2024-10-31
AusBiotech 2024 Opening Ceremony: From Local to Global – Shaping the Future of Life Sciences and Biotech in Australia
2024-10-30
AMS BioteQ Showcases Game-Changing Innovations at Medical Japan 2024
2024-10-29
AusBiotech 2024 to Highlight Global Areas of Interest, Current Trends, and Research Directives in Australia’s Diverse Biotech Industry
2024-10-25
BPIPO and DCB Collaborate with NVIDIA to Host AI Forum, Focusing on Cross-Domain Integration for Precision Health
2024-10-25
CDMO Samsung Bio Secures Record $1.24 Billion Biopharma Manufacturing Contract, Raising Total 2024 Deal Value to Over $3.3 Billion
2024-10-23
EVENT
2024-11-04
BIO-Europe 2024
Stockholm, Sweden
Scroll to Top